Wang Jian, Li Haozhe, Su Qiangfei, Liu Jingwei, Li Kang, Wang Zheng, Wang Lin
Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Hubei Key Laboratory of Regenerative Medicine and Multi-disciplinary Translational Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Bioact Mater. 2025 May 27;51:575-597. doi: 10.1016/j.bioactmat.2025.05.023. eCollection 2025 Sep.
The burgeoning field of algal biomedicine capitalizes on evolutionarily refined biological systems to address critical challenges in therapeutic delivery and tissue regeneration. As autotrophic biosystems, unicellular algae uniquely possess multi-functions, including oxygen generation, dynamic motility, fluorescence imaging, and programmable biosynthesis. Their photosynthetic systems not only generate therapeutic oxygen/hydrogen gradients but also facilitate chlorophyll-mediated therapeutics through inherent fluorescence and photodynamic effects. Beyond their metabolic versatility, flagellar propulsion systems, unique morphologies (, helical, elongated), and easily modified surfaces enable precision engineering of algae-based biohybrid microswimmers for spatiotemporally controlled drug delivery. This review comprehensively elucidates mechanistic foundations and biomedical applications of algae-based therapeutic platforms. Spontaneous and persistent oxygen production of algae could rescue hypoxic neurons or cardiomyocytes in myocardial infarction and ischemic stroke lesions, while ameliorating the hypoxia of skin fibroblasts to accelerate wound healing. In addition, increased oxygen levels enable the improvement of hypoxic tumor microenvironments to enhance the sensitivity of chemotherapy/radiotherapy to malignancies. Moreover, many versatile algae-based microswimmers have been developed for delivering therapeutic agents to treat gastrointestinal diseases and bacterial infections. It is believed that these photosynthetic microorganisms have great potential for being developed as next-generation platforms to address growing biomedical challenges.
新兴的藻类生物医学领域利用经过进化优化的生物系统来应对治疗递送和组织再生方面的关键挑战。作为自养生物系统,单细胞藻类独特地具有多种功能,包括氧气生成、动态运动、荧光成像和可编程生物合成。它们的光合系统不仅能产生治疗性的氧气/氢气梯度,还能通过内在的荧光和光动力效应促进叶绿素介导的治疗。除了其代谢的多功能性外,鞭毛推进系统、独特的形态(如螺旋形、细长形)以及易于修饰的表面,使得基于藻类的生物杂交微游动器能够进行精确工程设计,以实现时空可控的药物递送。本综述全面阐明了基于藻类的治疗平台的作用机制和生物医学应用。藻类自发且持续产生的氧气可以挽救心肌梗死和缺血性中风病变中的缺氧神经元或心肌细胞,同时改善皮肤成纤维细胞的缺氧状况以加速伤口愈合。此外,提高氧气水平能够改善缺氧的肿瘤微环境,增强化疗/放疗对恶性肿瘤的敏感性。而且,已经开发出许多多功能的基于藻类的微游动器用于递送治疗剂,以治疗胃肠道疾病和细菌感染。人们认为,这些光合微生物作为应对日益增长的生物医学挑战的下一代平台具有巨大的开发潜力。